Obalon Therapeutics, Inc.
(NASDAQ : OBLN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.14%97.360.6%$576.96m
ABTAbbott Laboratories
-0.38%81.910.8%$391.28m
TMOThermo Fisher Scientific Inc.
0.05%285.411.0%$387.84m
ISRGIntuitive Surgical, Inc.
1.50%503.992.4%$377.80m
BSXBoston Scientific Corporation
0.48%40.621.1%$320.37m
BDXBecton, Dickinson and Company
0.28%234.821.1%$311.42m
ALGNAlign Technology, Inc.
-5.34%289.386.3%$251.64m
EWEdwards Lifesciences Corporation
0.35%184.571.2%$213.20m
SYKStryker Corporation
0.17%195.801.3%$198.27m
DXCMDexCom, Inc.
1.12%149.708.3%$193.97m
BAXBaxter International Inc.
0.73%78.501.7%$174.62m
ABMDABIOMED, Inc.
1.05%253.593.3%$174.05m
ZBHZimmer Biomet Holdings, Inc.
-0.32%117.081.7%$119.36m
WATWaters Corporation
0.53%204.283.8%$113.02m
IDXXIDEXX Laboratories, Inc.
-0.46%266.513.7%$102.10m

Company Profile

Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded in January 2008 and is headquartered in San Diego, CA.